News Conference News CX Symposium 2025 Plant-Derived Compound Shows Early Promise for Small AAAs In aneurysms normally chosen for surveillance, the endovascular technique slowed growth by 70% in the small phase I trial. L.A. McKeown April 25, 2025
Presentation ACC 2025 STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes Presenter: Marc P. Bonaca March 29, 2025
Presentation ACC 2025 Extended Anticoagulant Treatment With A Reduced Versus Full Dose Apixaban In Patients With Cancer-associated Venous Thromboembolism: The API-CAT Study Presenter: Isabelle Mahé March 29, 2025
Presentation Miami Valves 2025 A Past Medical History of PE or DVT Impacts In-Hospital Outcomes of Patients Undergoing Elective Isolated Percutaneous Aortic Valve Replacement Presenter: Lourdes Villarrubia Varela January 30, 2025
Presentation Miami Valves 2025 Something in the Way: An RV in Crisis Presenter: Enrique Soltero Mariscal January 30, 2025
Presentation Cardiovascular Interventions 2024 Building Your PERT Team: Designing the Right Team with the Right Technology Presenter: Curtiss T. Stinis November 11, 2024
News Conference News CX Symposium 2025 Plant-Derived Compound Shows Early Promise for Small AAAs By L.A. McKeown April 25, 2025
News Conference News CX Symposium 2025 Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK By L.A. McKeown April 24, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices By L.A. McKeown April 23, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2025 By Caitlin E. Cox April 01, 2025